文献速递耳科与耳神经小儿耳鼻咽喉

大型听障与糖尿病人群中线粒体m.3243A>G变异筛查

Screening for Maternally Inherited Diabetes and Deafness in Large Cohorts of Hearing Impaired and Diabetic Patients.
PubMed 文献 · Ear Hear · 2026-02-10

该研究在斯洛伐克5957例听力损失和糖尿病患者中筛查m.3243A>G变异,检出25例携带者(0.42%),遗传性听力损失组和单基因糖尿病组检出率更高。颊粘膜异质性水平与听力损失和糖尿病发病年龄更相关,而年龄校正血液异质性水平与疾病总体严重程度相关。

要点

  • 遗传性听力损失和单基因糖尿病人群中m.3243A>G检出率高于一般糖尿病人群。
  • 颊粘膜异质性水平可预测听力损失和糖尿病发病年龄。
  • 年龄校正血液异质性水平与疾病总体严重程度相关。

核心结论

  • 在遗传性听力损失和单基因糖尿病组中m.3243A>G诊断率高于一般糖尿病组。
  • 严格纳入同时有糖尿病和听力损失可能降低检出率,因表型表现不同或不完全。
  • 年龄校正血液异质性水平可预测m.3243A>G相关疾病总体严重程度,而颊粘膜异质性水平更好预测听力损失和糖尿病发病年龄。

研究设计与样本

  • 前瞻性筛查研究,通过3项独立全国性研究招募5957例先证者,包括遗传性听力损失组1145例、一般糖尿病组4158例和单基因糖尿病组654例。
  • 采用定量实时PCR和数字PCR检测外周血和/或颊粘膜DNA中m.3243A>G变异。
  • 收集变异携带者的听力学和其他临床数据以评估表型。

主要发现

  • 共检出25例m.3243A>G变异携带者,总检出率为0.42%。
  • 遗传性听力损失组检出率为0.79%,单基因糖尿病组为1.68%,一般糖尿病组为0.14%(p < 0.001)。
  • 在38名家庭成员中也检出了m.3243A>G变异。
  • 数字PCR检测的外周血异质性水平范围为0.04%至76%,颊粘膜样本范围为0.01%至92%。
  • 仅38%的m.3243A>G变异携带者同时有糖尿病和听力损失。

关键数值与推荐

  • m.3243A>G变异总检出率为0.42%。
  • 遗传性听力损失组检出率0.79%,单基因糖尿病组1.68%,一般糖尿病组0.14%(p < 0.001)。
  • 外周血异质性水平0.04%至76%,颊粘膜异质性水平0.01%至92%。
  • 38%的携带者同时有糖尿病和听力损失。
  • 典型听力图构型为平坦型(占受累耳的28%)和斜坡型(占受累耳的42%)。

临床怎么用

  • 对遗传性听力损失和单基因糖尿病患者应考虑进行m.3243A>G变异筛查。
  • 颊粘膜异质性水平可用于预测听力损失和糖尿病的发病年龄。
  • 年龄校正血液异质性水平可用于评估疾病总体严重程度。
  • 人工耳蜗植入在m.3243A>G变异携带者中可获得良好且长期稳定的功能结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Mitochondrial DNA (mtDNA) mutations account for up to 5% of hereditary hearing loss (HL) cases. Most commonly, the m.3243A>G mtDNA variant contributes to rare monogenic Maternally Inherited Diabetes and Deafness or Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like episodes syndromes. Different proportions of the mutated mtDNA (heteroplasmy) among the affected tissues result in variability in the clinical manifestation and severity of the phenotype. The aim of the presented study was to establish the prevalence of the m.3243A>G variant in large cohorts of patients with HL and diabetes in Slovakia and to evaluate the genotype-phenotype correlations and long-term cochlear implantation outcomes in a small subset. DESIGN: Probands (n = 5957) were recruited via 3 independent nationwide studies on HL (hereditary HL group, n = 1145) and diabetes (general diabetes group, n = 4158, and monogenic diabetes group, n = 654; total n = 4812). DNA from peripheral blood and/or buccal mucosa was tested for the presence of the m.3243A>G variant using two polymerase chain reaction (PCR) methods-quantitative real-time PCR and digital PCR. Audiological and other clinical data of the identified variant carriers were also collected for phenotype evaluation. RESULTS: We identified 25 probands harboring the m.3243A>G variant (0.42%). The prevalence was higher in the groups where genetic etiology was suspected-0.79% in the hereditary HL group and 1.68% in the monogenic diabetes group versus 0.14% in the general diabetes group ( p < 0.001). Furthermore, we have identified the m.3243A>G variant in 38 family members. Heteroplasmy levels assessed by digital PCR ranged between 0.04 and 76% in peripheral blood and 0.01 and 92% in buccal samples. In most individuals, the symptoms manifested in the fourth decade of life in affected subjects with the Maternally Inherited Diabetes and Deafness phenotype or isolated HL/diabetes, but as early as in the second decade in the probands with Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like episodes. We observed high phenotype variability, ranging from severe multisystemic involvement through isolated symptoms to asymptomatic young "dormant" or very low heteroplasmy carriers. Only 38% of individuals with the m.3243A>G variant had both diabetes and HL. The heteroplasmy levels from buccal swabs showed a better correlation with the age of onset of both HL and diabetes than the age-adjusted blood heteroplasmy. On the other hand, the age-adjusted blood heteroplasmy was associated with overall severity of the disease (i.e., with a higher number of clinical symptoms). We show that the most typical audiogram configurations are flat (28% of the affected ears) and sloping (42% of the affected ears). Three individuals identified as cochlear implant recipients showed excellent and long-term stable functional outcomes. In addition, the authors report the first case of successful stapes surgery in a patient with a confirmed mitochondrial disorder and otosclerosis. CONCLUSIONS: The diagnostic yield was higher in the hereditary HL and monogenic diabetes groups than in the general diabetes group. Implementation of rigorous inclusion criteria requiring the presence of both diabetes and HL may lead to a lower detection rate due to different or incomplete phenotype manifestation. Age-adjusted blood heteroplasmy levels seem to be a good predictor of overall severity of m.3243A>G-associated diseases, but buccal mucosa heteroplasmy predicted the age of HL and diabetes onset better.

来源:Ear Hear,查看原文。版权归原作者所有。

引用

  1. Varga L, Borecka S, Skopkova M, et al. Screening for Maternally Inherited Diabetes and Deafness in Large Cohorts of Hearing Impaired and Diabetic Patients. Ear Hear. 2026. PMID: 41664274. doi:10.1097/AUD.0000000000001780

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。